|
Volumn 36, Issue 2, 2001, Pages 329-331
|
Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody
|
Author keywords
Acute lymphoblastic leukemia; Child; Epstein Barr virus; Lymphoproliferative disorder; Monoclonal antibody
|
Indexed keywords
CD20 ANTIGEN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD20;
RITUXIMAB;
UNCLASSIFIED DRUG;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
B LYMPHOCYTE;
CASE REPORT;
CELL INFILTRATION;
CLINICAL FEATURE;
DIAGNOSTIC IMAGING;
DRUG EFFECT;
DRUG EFFICACY;
EPSTEIN BARR VIRUS;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
IMAGE ANALYSIS;
IMMUNE DEFICIENCY;
LYMPHOPROLIFERATIVE DISEASE;
PRIORITY JOURNAL;
SMALL INTESTINE PERFORATION;
TREATMENT OUTCOME;
VIRUS INFECTION;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
B-LYMPHOCYTES;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
LEUKEMIA, T-CELL, ACUTE;
LYMPHOPROLIFERATIVE DISORDERS;
|
EID: 0035143652
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/1096-911X(20010201)36:2<329::AID-MPO1077>3.0.CO;2-F Document Type: Article |
Times cited : (11)
|
References (11)
|